Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 2494: A pilot proteomic analysis to identify biomarker proteins in human pancreatic cancer using reverse phase protein array

View through CrossRef
Abstract Background: Pancreatic cancer is the fourth leading cause of cancer death in the U.S, and with an overall 5-year survival rate less than 4%. The high mortality rate of patients with pancreatic cancer is primarily due to the difficulty of early diagnosis and a lack of effective therapies. There is an urgent need to discover novel molecular targets for early diagnosis and new therapeutic approaches to improve the clinical outcome of this deadly disease. Reverse-phase protein assay (RPPA), a high throughput proteomic approach, provides us a platform to identify differentially expressed proteins and characterize posttranslational protein modifications involved in tumorigenesis. Methods: In the present study here, we carried out proteomic analysis of pancreatic cancer specimens with matched adjacent, normal-appearing tissue samples from 15 pancreatic cancer patients to evaluate the differentially expressed biomarker proteins. The antibody panel used for RPPA included 132 key proteins involved in various cancer-related pathways. The paired t test was used to determine the significant differences between matched pairs, and the false discovery rate-adjusted p values (q values) were calculated to take into account the effect of multiple comparisons. Result: Out of the panel of 132 proteins included in RPPA, we found 19 of them had statistically significant differences in expression between matched pairs (q <0.05). Among these 19 proteins, AKT, -catenin, GAB2, and PAI-1 were identified as differentially overexpressed in the pancreatic tumor (a fold change of T/N ≥ 1.5). In addition, overexpression of AKT, -catenin, and GAB2 in pancreatic cancer tissue identified in RPPA has been confirmed by western blot analysis. Further analysis identified several significantly associated canonical pathways and overrepresented network functions using the Ingenuity Pathway Analysis (IPA) tool. Conclusion: In conclusion, among the three proteins identified in RPPA and validated by western blot, overexpression of GAB2 has not been reported previously in pancreatic cancer. Considering the essential role of GAB2 in two major signaling pathways in cancer (the PI3-AKT and the ERK signaling pathways), identification of GAB2 in pancreatic cancer may provide additional insight into this cancer's pathogenesis. Citation Format: Yu-jing Huang, Nianxiang Zhang, Marsha Frazier, Chongjuan Wei. A pilot proteomic analysis to identify biomarker proteins in human pancreatic cancer using reverse phase protein array. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 2494. doi:10.1158/1538-7445.AM2014-2494
Title: Abstract 2494: A pilot proteomic analysis to identify biomarker proteins in human pancreatic cancer using reverse phase protein array
Description:
Abstract Background: Pancreatic cancer is the fourth leading cause of cancer death in the U.
S, and with an overall 5-year survival rate less than 4%.
The high mortality rate of patients with pancreatic cancer is primarily due to the difficulty of early diagnosis and a lack of effective therapies.
There is an urgent need to discover novel molecular targets for early diagnosis and new therapeutic approaches to improve the clinical outcome of this deadly disease.
Reverse-phase protein assay (RPPA), a high throughput proteomic approach, provides us a platform to identify differentially expressed proteins and characterize posttranslational protein modifications involved in tumorigenesis.
Methods: In the present study here, we carried out proteomic analysis of pancreatic cancer specimens with matched adjacent, normal-appearing tissue samples from 15 pancreatic cancer patients to evaluate the differentially expressed biomarker proteins.
The antibody panel used for RPPA included 132 key proteins involved in various cancer-related pathways.
The paired t test was used to determine the significant differences between matched pairs, and the false discovery rate-adjusted p values (q values) were calculated to take into account the effect of multiple comparisons.
Result: Out of the panel of 132 proteins included in RPPA, we found 19 of them had statistically significant differences in expression between matched pairs (q <0.
05).
Among these 19 proteins, AKT, -catenin, GAB2, and PAI-1 were identified as differentially overexpressed in the pancreatic tumor (a fold change of T/N ≥ 1.
5).
In addition, overexpression of AKT, -catenin, and GAB2 in pancreatic cancer tissue identified in RPPA has been confirmed by western blot analysis.
Further analysis identified several significantly associated canonical pathways and overrepresented network functions using the Ingenuity Pathway Analysis (IPA) tool.
Conclusion: In conclusion, among the three proteins identified in RPPA and validated by western blot, overexpression of GAB2 has not been reported previously in pancreatic cancer.
Considering the essential role of GAB2 in two major signaling pathways in cancer (the PI3-AKT and the ERK signaling pathways), identification of GAB2 in pancreatic cancer may provide additional insight into this cancer's pathogenesis.
Citation Format: Yu-jing Huang, Nianxiang Zhang, Marsha Frazier, Chongjuan Wei.
A pilot proteomic analysis to identify biomarker proteins in human pancreatic cancer using reverse phase protein array.
[abstract].
In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA.
Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 2494.
doi:10.
1158/1538-7445.
AM2014-2494.

Related Results

7 th International Symposium on Enabling Technologies for Life Sciences (ETP)
7 th International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see Rapid Communications in Mass Spectrometry 2012, 26 , ...
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract Pancreatic adenocarcinoma (PDAC) remains one of the most lethal cancers today and is expected to be the second cause of cancer death in the coming decade. M...
Laboratory Model Study of Single Five-Spot and Single Injection Well Pilot Waterflooding
Laboratory Model Study of Single Five-Spot and Single Injection Well Pilot Waterflooding
Abstract Many full-scale waterflooding operations are preceded by pilot floods, one purpose of which is to provide an estimate of recoverable oil. A laboratory mo...
Abstract LB-80: Building Bridges for Pancreatic Cancer Research
Abstract LB-80: Building Bridges for Pancreatic Cancer Research
Abstract Almost 40 years after President Nixon signed into law the National Cancer Act, the survival rate for pancreatic cancer has not substantially improved. Today...
Abstract 675: Performance of highly sensitive molecular biomarker for pancreatic cancer detection
Abstract 675: Performance of highly sensitive molecular biomarker for pancreatic cancer detection
Background: Pancreatic cancer is one of the most lethal malignancies, with resection being the only potentially curative treatment. However, due to the absence of...
Abstract 1695: Imaging of the interaction of pancreatic cancer and stellate cells during liver metastasis
Abstract 1695: Imaging of the interaction of pancreatic cancer and stellate cells during liver metastasis
Abstract Pancreatic stellate cells are involved in fibrosis of pancreatic cancer. An understanding of pancreatic cancer-cell interactions with stellate cells is crit...
Abstract 1603: Intra-pancreatic fat promotes the progression of PDAC by activating thermogenesis
Abstract 1603: Intra-pancreatic fat promotes the progression of PDAC by activating thermogenesis
Abstract Background: The presence of minimal intra-pancreatic fat deposition (IPFD) in the healthy human pancreas has been demonstrated in numerous studies. But exce...
The Dual Effects of Silibinin on Human Pancreatic Cells
The Dual Effects of Silibinin on Human Pancreatic Cells
Objective: Silibinin is a flavonoid with antihepatotoxic properties, and exhibits pleiotropic anticancer effects. However, the molecular mechanisms responsible for its anticancer a...

Back to Top